Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Little Green Pharma Ltd
  6. Summary
    LGP   AU0000074924

LITTLE GREEN PHARMA LTD

(LGP)
  Report
Delayed Australian Stock Exchange  -  11:08:09 2023-01-26 pm EST
0.2050 AUD   -2.38%
01/16Seed Innovations hails Little Green's "record" cash receipts
AN
2022Little Green Pharma Extends Share Purchase Plan
MT
2022Seed Innovations subsidiary secures second cannabis deal in Denmark
AN
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusFunds 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
01/23/2023 01/24/2023 01/25/2023 01/27/2023 01/26/2023 Date
0.21(c) 0.21(c) 0.21(c) 0.205(c) 0.205 Last
489 312 357 944 288 993 171 966 171 966 Volume
+16.67% 0.00% 0.00% -2.38% -2.38% Change
More quotes
Estimated financial data (e)
Sales 2021 7,00 M 4,98 M 4,98 M
Net income 2021 24,6 M 17,5 M 17,5 M
Net cash position 2021 27,5 M 19,5 M 19,5 M
P/E ratio 2021 4,72x
Yield 2021 -
Sales 2022 14,0 M 9,98 M 9,98 M
Net income 2022 -24,4 M -17,3 M -17,3 M
Net cash position 2022 4,21 M 2,99 M 2,99 M
P/E ratio 2022 -4,69x
Yield 2022 -
Capitalization 54,4 M 38,7 M 38,7 M
EV / Sales 2021 14,8x
EV / Sales 2022 8,00x
Nbr of Employees 120
Free-Float 66,6%
More Financials
Company
Little Green Pharma Ltd is an Australia-based medicinal cannabis company. The Company is engaged in the cultivation of medicinal cannabis, procurement of raw materials and the production of medicinal cannabis medicines. It has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being over 21,500 square... 
Sector
Pharmaceuticals
Calendar
01/31 | 02:00amShareholder meeting
More about the company
All news about LITTLE GREEN PHARMA LTD
01/16Seed Innovations hails Little Green's "record" cash receipts
AN
2022Little Green Pharma Extends Share Purchase Plan
MT
2022Seed Innovations subsidiary secures second cannabis deal in Denmark
AN
2022Little Green Pharma Secures AU$4.5 Million Cannabis Product Supply Deal; Shares Up 3%
MT
2022Little Green Pharma Secures Ethics Approval for Phase 3 Clinical Trial of CBD-based Ins..
MT
2022Little Green Pharma Ltd. Obtains Ethics Approval for its Proposed Multi-Site, Placebo-C..
CI
2022Little Green Pharma Ltd Reports Earnings Results for the Half Year Ended September 30, ..
CI
2022Little Green Pharma Receives Cannabis Flower Supply for Australian Market; Shares Rally..
MT
2022Little Green Pharma Ltd Significantly Expands Flower Portfolio
CI
2022Little Green Pharma Ltd Provides Update on French Trial Extension
CI
2022Little Green Pharma to Raise $2.5 Million in Share Placement
MT
2022Little Green Pharma Logs Record $3 Million Revenue in Fiscal Q2
MT
2022Little Green Pharma Rises 6% After Securing Supply Deal With German Cannabis Company
MT
2022Little Green Pharma : Quarterly Activities Report & Appendix 4C
PU
2022Little Green Pharma : Application for quotation of securities - LGP
PU
More news
News in other languages on LITTLE GREEN PHARMA LTD
01/16Seed Innovations salue les rentrées d'argent "record" de Little Green
2022Little Green Pharma décroche un contrat d'approvisionnement en produits à base de canna..
2022Little Green Pharma Ltd. Obtient l'approbation éthique pour son projet d'essai pharmaco..
2022Little Green Pharma Ltd annonce ses résultats pour le semestre clos le 30 septembre 202..
2022Little Green Pharma reçoit un approvisionnement en fleurs de cannabis pour le marché au..
More news
Chart LITTLE GREEN PHARMA LTD
Duration : Period :
Little Green Pharma Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LITTLE GREEN PHARMA LTD
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 0,21
Average target price
Spread / Average Target -
Managers and Directors
Fleta Jennifer Solomon Chief Executive Officer, Director & MD
Morten Snede Chief Financial Officer
Michael David Lynch-Bell Independent Non-Executive Chairman
Leon Warne Head-Research & Innovation
Paul Long Chief Operating Officer